{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:47:05Z","timestamp":1772261225041,"version":"3.50.1"},"reference-count":23,"publisher":"National Center for Global Health and Medicine (JST)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["GHM"],"published-print":{"date-parts":[[2026,2,25]]},"DOI":"10.35772\/ghm.2026.01003","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:08:26Z","timestamp":1770502106000},"page":"39-52","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective observational analysis of prasugrel dosage after percutaneous coronary intervention using the Clinical Deep Data Accumulation System database"],"prefix":"10.35772","volume":"8","author":[{"given":"Yukio","family":"Hiroi","sequence":"first","affiliation":[{"name":"Department of Cardiology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iori","family":"Kajikawa","sequence":"additional","affiliation":[{"name":"Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kodera","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arihiro","family":"Kiyosue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan."},{"name":"Department of Cardiovascular Medicine, Moriyama Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan."},{"name":"Development Bank of Japan Inc., Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Open Innovation Center, National Cerebral and Cardiovascular Center, Suita, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics, Tohoku University Graduate School of Medicine, Miyagi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan."},{"name":"Department of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kabutoya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Imai","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisaki","family":"Makimoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Jichi Medical University, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Kohro","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Jichi Medical University, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Akashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Informatics, Jichi Medical University, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Clinical Informatics, Jichi Medical University, Tochigi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jichi Medical University Saitama Medical Center, Saitama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"CLIDAS Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21485","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357:2001-2015.","DOI":"10.1056\/NEJMoa0706482"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Nakamura M. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study. Circ J. 2014; 78:1684-1692.","DOI":"10.1253\/circj.CJ-13-1482"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Saito S; PRASFIT-Elective Investigators. Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention. Circ J. 2014; 78:2926-2934.","DOI":"10.1253\/circj.CJ-14-0266"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakamura M, Kitazono T, Kozuma K, Sekine T, Nakamura S, Shiosakai K, Tanabe A, Iizuka T. Prasugrel for Japanese patients with ischemic heart disease in long-term clinical practice (PRASFIT-Practice II) - final 2-year follow-up results of a postmarketing observational study. Circ J. 2020; 84:1981-1989.","DOI":"10.1253\/circj.CJ-20-0253"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kitagawa K, Toyoda K, Kitazono T, Nishikawa M, Nanto S, Ikeda Y, Abe K, Ogawa A. Safety and efficacy of prasugrel in elderly\/low body weight Japanese patients with ischemic stroke: Randomized PRASTRO-II. Cerebrovasc Dis. 2020; 49:152-159.","DOI":"10.1159\/000506825"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kimura T, Isshiki T, Ogawa H, Yokoi H, Yamaguchi T, Ikeda Y. Randomized, double-blind, dose-finding, phase II study of prasugrel in Japanese patients undergoing elective percutaneous coronary intervention. J Atheroscler Thromb. 2015; 22:557-569.","DOI":"10.5551\/jat.26013"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kimura M, Nakayasu K, Ohshima Y, <i>et al<\/i>. SS-MIX: A ministry project to promote standardized healthcare information exchange. Methods Inf Med. 2011; 50:131-139.","DOI":"10.3414\/ME10-01-0015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matoba T, Kohro T, Fujita H, Nakayama M, Kiyosue A, Miyamoto Y, Nishimura K, Hashimoto H, Antoku Y, Nakashima N, Ohe K, Ogawa H, Tsutsui H, Nagai R. Architecture of the Japan ischemic heart disease multimodal prospective data acquisition for precision treatment (J-IMPACT) system. Int Heart J. 2019; 60:264-270.","DOI":"10.1536\/ihj.18-113"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ikebe S, Ishii M, Otsuka Y, <i>et al<\/i>. Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events. Int J Cardiol Cardiovasc Risk Prev. 2023; 18:200193.","DOI":"10.1016\/j.ijcrp.2023.200193"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nochioka K, Nakayama M, Akashi N, <i>et al<\/i>. Change in pulse pressure and cardiovascular outcomes after percutaneous coronary intervention: The CLIDAS study. Int J Cardiol Heart Vasc. 2024; 53:101430.","DOI":"10.1016\/j.ijcha.2024.101430"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matoba T, Katsuki S, Nakano Y, <i>et al<\/i>. Efficacy and safety of high-intensity statins in Japanese patients after percutaneous coronary intervention \u2013 Insights From the Clinical Deep Data Accumulation System (CLIDAS\u00ae). Circ J. 2025; 89:1204-1215.","DOI":"10.1253\/circj.CJ-25-0066"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Otsuka Y, Ishii M, Ikebe S, <i>et al<\/i>. Long-term bleeding events post-percutaneous coronary intervention in patients with malignancy with and without anticoagulant therapy. Cardiovasc Interv Ther. 2025; 40:796-806.","DOI":"10.1007\/s12928-025-01151-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Makimoto H, Sasabuchi Y, Kabutoya T, <i>et al<\/i>. Preventive effects of prasugrel on cerebrovascular events following percutaneous coronary intervention. Stroke. 2025; 56:2101-2109.","DOI":"10.1161\/STROKEAHA.125.050366"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Oba Y, Kabutoya T, Kohro T, <i>et al<\/i>. Relationships among heart rate, \u03b2-blocker dosage, and prognosis in patients with coronary artery disease in a real-world database using a multimodal data acquisition system. Circ J. 2023; 87:336-344.","DOI":"10.1253\/circj.CJ-22-0314"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53:982-992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Collet JP, Thiele H, Barbato E, <i>et al<\/i>. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021; 42:1289-1367.","DOI":"10.1093\/eurheartj\/ehaa909"},{"key":"17","unstructured":"17. Rao SV, O&apos;Donoghue ML, Ruel M, <i>et al<\/i>. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025; 151:e771-e862."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Capodanno D, Mehran R, Krucoff MW, <i>et al<\/i>. Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: A consensus document from the Academic Research Consortium. Circulation. 2023; 147:1933-1944.","DOI":"10.1161\/CIRCULATIONAHA.123.064473"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Watanabe H, Morimoto T, Natsuaki M, <i>et al<\/i>. Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: The STOPDAPT-2 ACS randomized clinical trial. JAMA Cardiol. 2022; 7:407-417.","DOI":"10.1001\/jamacardio.2021.5244"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Akita K, Inohara T, Yamaji K, Kohsaka S, Numasawa Y, Ishii H, Amano T, Kadota K, Nakamura M, Maekawa Y. Impact of reduced-dose prasugrel <i>vs<\/i>. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62,737 patients with acute coronary syndromes: A nationwide registry study in Japan. Eur Heart J Cardiovasc Pharmacother. 2020; 6:231-238.","DOI":"10.1093\/ehjcvp\/pvz056"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shoji S, Sawano M, Sandhu AT, Heidenreich PA, Shiraishi Y, Ikemura N, Ueno K, Suzuki M, Numasawa Y, Fukuda K, Kohsaka S. Ischemic and bleeding events among patients with acute coronary syndrome associated with low-dose prasugrel <i>vs<\/i> standard-dose clopidogrel treatment. JAMA Netw Open. 2020; 3:e202004.","DOI":"10.1001\/jamanetworkopen.2020.2004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yokoi H, Kimura T, Isshiki T, Ogawa H, Ikeda Y. Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention. Thromb Res. 2012; 129:623-628.","DOI":"10.1016\/j.thromres.2011.11.023"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nishikawa M, Isshiki T, Kimura T, Ogawa H, Yokoi H, Miyazaki S, Ikeda Y, Nakamura M, Tanaka Y, Saito S. Risk of bleeding and repeated bleeding events in prasugrel-treated patients: A review of data from the Japanese PRASFIT studies. Cardiovasc Interv Ther. 2017; 32:93-105.","DOI":"10.1007\/s12928-016-0452-7"}],"container-title":["Global Health &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/8\/1\/8_2026.01003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:21:08Z","timestamp":1772252468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/8\/1\/8_2026.01003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.35772\/ghm.2026.01003","relation":{},"ISSN":["2434-9186","2434-9194"],"issn-type":[{"value":"2434-9186","type":"print"},{"value":"2434-9194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"2026.01003"}}